Publications describing the use of

The Infant's Dermatitis Quality of Life Index


1.         Lewis-Jones MS, Finlay AY, Dykes PJ.  Measurement of the impact of atopic dermatitis on infant’s and their families lives.  British Journal of Dermatology 1999; 141 (Suppl 55): 105-106.

2.         Lewis-Jones M S, Finlay A Y, Dykes P J.  The Infants’ Dermatitis Quality of Life Index.  Br J Dermatol 2001 144: 104-10

3.        Chinn D J, Poyner T, Sibley G.  Randomized controlled of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema.  Br J Dermatol 2002; 146: 432-9.

4.        Taieb C, Myon E, Perez N, Finlay A Y.  Quality of life and atopic dermatitis:  annual assessment in France. JEADV 2003; 17: 61.

5.        Beattie P E, Lewis-Jones M S.  A pilot study on the use of wet wraps in moderate atopic eczema. Br J Dermatol 2003; 149 (Suppl 64):  4.

6.         Taieb C, Macy G, Sibaud V, Myon E.  Atopic dermatitis and quality of life:  French evaluation in young children.  JEADV  2003; 17 (Suppl 3):  177.

7.         Grad O, Niren N, Sung J, Law A.  Impact of atopic dermatitis treatment on quality of life:  Results from findings in atopic children with eczema (face) study.    J Am Acad Dermatol 2004; 50(3): P65.

8.         Myon E, Taieb C, Macy G, Sibaud V.  Atopic dermatitis and patient education:  European evaluation in young children.  JEADV 2004; 18 (Suppl 1): 77.

9.         Austin E, Phillips G, Lewis-Jones S.  The prevalence of fusidic acid-resistant Staphylococcus aureus colonization in paediatric outpatients with atopic dermatitis.  BJD 151 (Suppl 68):74.

10.      Beattie P E, Lewis-Jones M S.  A pilot study on the use of wet wraps in infants with moderate atopic eczema.  Clin Exp Dermatol 2004; 29(4): 348-353.

11.      Taeb C, Macy G, Sibaud V, Myon E.  Atopic dermatitis:  European evaluation in young children.  JEADV 2004; 18 (Suppl 2) 300.

12.      Beattie P E, Lewis-Jones M S.  An audit of the usefulness of quality of life measures in secondary care for assessing the impact of atopic dermatitis on infants and their families and the benefit obtained from consultation with a dermatology team.  BJD 2005; 153 (Suppl 1): 82.

13.     Beattie P E, Lewis-Jones M S.  An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families:  further validation of the Infants’ Dermatitis Quality of Life Index and Dermatitis Family Impact Score.  BJD 2006; 155: 1249-1255.

14.      Holme E A, Esmann S, Jemec G B E.  Parent gender and assessment of infant life quality.  JEADV 2006; 20: 274-276.

15.      Msika P.  New natural PPAR-a agonist for childhood atopic dermatitis:  Dermocorti-coid-sparing and quality of life improvement.  J Am Acad Dermatol 2007; February AB67.

16.      de Belilovsky C, Chdoutaud B, Msika P.  Cosmetics and quality of life.  JEADV 2007;

17.     Shaw M, Morrell D S, Goldsmith L A.  A Study of Targeted Enhanced Patient care for Pediatric Atopic Dermatitis (STEP PAD).  Pediatric Dermatology 2008; 25: 19-24.